RARE

NASDAQ · Biotechnology

Ultragenyx Pharmaceutical In

Small-Cap Stocks Biotech Stocks Healthcare Stocks

$14.51

+0.01 (+0.07%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 23 88%

Hold 3 12%

Sell 0 0%

Price Target

Analyst Price Target +413.0% upside

Low Target $68.49

Average Target $74.44

High Target $103.74

Current Price $14.51

Current
$14.51

Target
$74.44

$68.49 $74.44 avg $103.74

Scenario Analysis

Bear Case

$68.49

372.0%

Low target

Base Case

$74.44

+413.0%

Avg target

Bull Case

$103.74

+615.0%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$39.89

-63.6% from high

52-Week Low

$12.73

+14.0% from low

50-Day SMA

$26.56

-45.4% vs SMA

200-Day SMA

$31.06

-53.3% vs SMA

RSI (14)

37.4

Neutral

Target vs 52W High

$74.44

+86.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.7%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+139.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.3%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.3%
MRNA Moderna Inc	Hold	30	37%	$149.45	-3.0%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%